20-59322388-GA-GAA

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 4P and 12B. PVS1_StrongBP6_Very_StrongBS2

The NM_207034.3(EDN3):​c.565dupA​(p.Thr189AsnfsTer10) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00262 in 1,614,168 control chromosomes in the GnomAD database, including 9 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0028 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 9 hom. )

Consequence

EDN3
NM_207034.3 frameshift

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1U:1B:7

Conservation

PhyloP100: -1.53

Publications

6 publications found
Variant links:
Genes affected
EDN3 (HGNC:3178): (endothelin 3) The protein encoded by this gene is a member of the endothelin family. Endothelins are endothelium-derived vasoactive peptides involved in a variety of biological functions. The active form of this protein is a 21 amino acid peptide processed from the precursor protein. The active peptide is a ligand for endothelin receptor type B (EDNRB). The interaction of this endothelin with EDNRB is essential for development of neural crest-derived cell lineages, such as melanocytes and enteric neurons. Mutations in this gene and EDNRB have been associated with Hirschsprung disease (HSCR) and Waardenburg syndrome (WS), which are congenital disorders involving neural crest-derived cells. Altered expression of this gene is implicated in tumorigenesis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
EDN3 Gene-Disease associations (from GenCC):
  • Waardenburg syndrome type 4B
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P
  • Waardenburg syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Waardenburg-Shah syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease, susceptibility to, 4
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.211 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
BP6
Variant 20-59322388-G-GA is Benign according to our data. Variant chr20-59322388-G-GA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 227351.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 9 AR,AD,SD,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_207034.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EDN3
NM_207034.3
MANE Select
c.565dupAp.Thr189AsnfsTer10
frameshift
Exon 4 of 5NP_996917.1P14138-1
EDN3
NM_001424362.1
c.565dupAp.Thr189AsnfsTer23
frameshift
Exon 4 of 5NP_001411291.1
EDN3
NM_207032.3
c.565dupAp.Thr189AsnfsTer63
frameshift
Exon 4 of 5NP_996915.1P14138-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EDN3
ENST00000337938.7
TSL:1 MANE Select
c.565dupAp.Thr189AsnfsTer10
frameshift
Exon 4 of 5ENSP00000337128.2P14138-1
EDN3
ENST00000311585.11
TSL:1
c.565dupAp.Thr189AsnfsTer63
frameshift
Exon 4 of 5ENSP00000311854.7P14138-3
EDN3
ENST00000395654.3
TSL:1
c.542+1201dupA
intron
N/AENSP00000379015.3P14138-2

Frequencies

GnomAD3 genomes
AF:
0.00277
AC:
421
AN:
152192
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00508
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00356
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.00213
AC:
535
AN:
251422
AF XY:
0.00210
show subpopulations
Gnomad AFR exome
AF:
0.00271
Gnomad AMR exome
AF:
0.000838
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00587
Gnomad NFE exome
AF:
0.00273
Gnomad OTH exome
AF:
0.00228
GnomAD4 exome
AF:
0.00260
AC:
3805
AN:
1461858
Hom.:
9
Cov.:
32
AF XY:
0.00257
AC XY:
1871
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.00206
AC:
69
AN:
33478
American (AMR)
AF:
0.000827
AC:
37
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000429
AC:
37
AN:
86258
European-Finnish (FIN)
AF:
0.00657
AC:
351
AN:
53410
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00281
AC:
3124
AN:
1111992
Other (OTH)
AF:
0.00301
AC:
182
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
220
440
660
880
1100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00276
AC:
421
AN:
152310
Hom.:
0
Cov.:
32
AF XY:
0.00286
AC XY:
213
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00243
AC:
101
AN:
41578
American (AMR)
AF:
0.00131
AC:
20
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4824
European-Finnish (FIN)
AF:
0.00508
AC:
54
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00354
AC:
241
AN:
68014
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
21
42
63
84
105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00206
Hom.:
0
Bravo
AF:
0.00235
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.00267
EpiControl
AF:
0.00273

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
1
-
-
Aganglionic megacolon (1)
-
1
-
Congenital central hypoventilation (1)
-
-
1
EDN3-related disorder (1)
-
-
1
Hirschsprung Disease, Dominant (1)
-
-
1
not specified (1)
-
-
1
Waardenburg syndrome type 4B (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-1.5
Mutation Taster
=74/126
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11570344; hg19: chr20-57897443; COSMIC: COSV61107582; API